AbbVie
 @abbvie

Official global handle sharing the latest news about our company, science & people. Review our guidelines: bit.ly/abbvie-social-media

 Global
AbbVie.com
Joined March 2012
[Video description: A conversation between Dr. Leonard Calabrese, board-certified rheumatologist, and Cheryl Crow, rheumatoid arthritis patient advocate, on the importance of open patient-doctor conversations to find appropriate care plans for rheumatic disease patients.]
2
#AbbViePartner | Hear from @LCalabreseDO & @realcc about the importance of open patient-doctor conversations to find an appropriate care plan for people living with rheumatic diseases. Learn more: abbv.ie/a26bb2. #RheumForDialogue For U.S. Audiences Only
2
2
1
5
0
At this year’s 2025 #NEICongress, we’ll be joining healthcare teams and industry experts as they share the latest developments in #MentalHealth care. If you’re in attendance, check out our booth: abbv.ie/251a77
2
5
Join us live: Our Q3 2025 #earnings call is starting: abbv.ie/4dbc38 $ABBV
1
1
1
5
[Video description: AbbVie logo followed by graph animations, with text reading, "Q3 2025 Financial Results."]
2
"AbbVie continues to deliver outstanding results, with significant momentum across key areas of our portfolio," said Robert A. Michael, our Chairman of the Board and CEO. Our Q3 2025 #FinancialResults are in. See them here: abbv.ie/91e75a $ABBV #earnings
1
1
10
0
Reminder: Join us tomorrow at 8am CT as we share our Q3 2025 #FinancialResults. abbv.ie/4dbc38 #earnings $ABBV
1
4
[Video description: An icon depicting a pie chart. On-screen text reads, "Join us for our Q3 2025 Earnings Call & Webcast. October 31 at 8 a.m. CT."]
1
2
Join our #investor call this Friday, October 31, at 8am CT, where we'll share our Q3 2025 #FinancialResults. abbv.ie/4dbc38 #earnings $ABBV
5
1
2
5
0
Andy Anisfeld and Casey Schlacher highlight findings from our new #rheumatology research at #ACR25, demonstrating how scientific advances are informing potential treatment approaches and helping elevate care for patients with immune-mediated rheumatologic conditions.
6
Video description: Interview with Jordan Feld, Hepatologist & Liver specialist, the University of Toronto, Canada. On-screen text reads, “An estimated 36% of people with HCV knew of their diagnosis and ~75%–85% are asymptomatic. Join us as we work to help eliminate Hepatitis C.”
#HepatitisC is oftentimes asymptomatic, which can lead to serious complications such as #LiverCancer as the disease progresses. October is #LiverCancerAwarenessMonth and we’re emphasizing our focus on #HCV elimination and advancing progress in the global community. Learn more ⬇️
2
1
3
0
[Video description: On-screen text reads, “Immunology News.”]
JUST IN: Topline results from our Phase 3b/4 head-to-head study among patients with moderate to severe #RheumatoidArthritis (RA) announced today. Read more: abbv.ie/o62c #Immunology
1
1
3
0
[Video description: On-screen text reads, "Neuroscience News"]
1
We've completed the acquisition of Gilgamesh Pharmaceuticals' lead investigational asset. This expands our #psychiatry pipeline and underscores our commitment to pursue innovative approaches for #MentalHealth disorders. More: abbv.ie/4ce3d8
3
4
2
8
0
[Video description: On-screen text reads, “Immunology News.”]
At #ACR25, we’re presenting over 20 abstracts, highlighting new data across our diverse #rheumatology portfolio. Learn more about our commitment to improving outcomes for patients with immune-mediated rheumatologic conditions: abbv.ie/b840c4
2
1
6
0
Ovarian cancer doesn’t just have a physical impact – it can profoundly affect mental and emotional well-being as well. Explore more about the emotional impact of living with ovarian cancer: abbv.ie/cf3bc1 #FacesofOvarianCancer #ESMO25
1
5
JUST IN: We're launching a five-year strategic alliance with @MoffittNews - which aims to accelerate the development of new #cancer therapies and expand #patient treatment options. Read more. ⬇️
Moffitt Cancer Center
 @MoffittNews
Oct 14
x.com/i/article/197808672194…
1
3
Load more